InvestorsHub Logo
Followers 34
Posts 3040
Boards Moderated 0
Alias Born 01/26/2011

Re: RedShoulder post# 439465

Monday, 11/20/2023 12:19:29 PM

Monday, November 20, 2023 12:19:29 PM

Post# of 458252
I wonder if today's news will be enough to convince Tom Bishop to make AVXL his "Top Pick For 2024" (if I recall correctly, he made AVXL his top pick for both 2022 and 2023)...

I think your point which I agree with, is the most important conclusion of today's news; that the completed AD Ph- 2b/3 will first be approved by the EMA; while getting Rett though with the FDA and eligible for the $100 Million voucher. Followed closely by the FDA accepting great AD data and importantly safety. You know when the EMA approves A2-73 Blarcamesine, that the FDA will be under tremendous pressure to approve.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News